This website uses cookies. If you do not want these cookies you can disable them here. Read more about our cookie statement.
On December 3rd and 4th we will attend the Biofit partnering event in Lille, France.
LinXis will attend EANM in Hamburg from October 19-23, where we will also present the preclinical results-to-date on our lead Fibrobody® in a Top Rated Oral Presentation.
Read all about the preclinical validation of our lead Fibrobody® in the European Journal of Nuclear Medicine and Molecular Imaging.
We are proud to welcome Guus van Dongen as our full-time CSO.
